| Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner D Bayik, Y Zhou, C Park, C Hong, D Vail, DJ Silver, A Lauko, G Roversi, ... Cancer discovery 10 (8), 1210-1225, 2020 | 155 | 2020 |
| Glioblastoma myeloid-derived suppressor cell subsets express differential macrophage migration inhibitory factor receptor profiles that can be targeted to reduce immune suppression TJ Alban, D Bayik, B Otvos, A Rabljenovic, L Leng, L Jia-Shiun, G Roversi, ... Frontiers in immunology 11, 1191, 2020 | 97 | 2020 |
| Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors A Lauko, A Lo, MS Ahluwalia, JD Lathia Seminars in Cancer Biology, 2021 | 82 | 2021 |
| Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell–Cell Interactions in Tumor Progression A Lauko, Z Mu, DH Gutmann, UP Naik, JD Lathia Cancer Research 80 (22), 4878-4885, 2020 | 40 | 2020 |
| GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity DC Watson, D Bayik, S Storevik, SS Moreino, SA Sprowls, J Han, ... Nature Cancer, 1-17, 2023 | 36 | 2023 |
| Management of Brain Metastases in the New Era of Checkpoint Inhibition A Lauko, B Thapa, VA Venur, MS Ahluwalia Current Neurology and Neuroscience Reports 18 (10), 70, 2018 | 36 | 2018 |
| Medical management of brain metastases A Lauko, Y Rauf, MS Ahluwalia Neuro-oncology advances 2 (1), vdaa015, 2020 | 32 | 2020 |
| JAM-A functions as a female microglial tumor suppressor in glioblastoma SM Turaga, DJ Silver, D Bayik, E Paouri, S Peng, A Lauko, TJ Alban, ... Neuro-Oncology, 2019 | 31 | 2019 |
| Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells J Volovetz, AD Berezovsky, T Alban, Y Chen, A Lauko, GF Aranjuez, ... Cell Death & Disease 11 (2), 1-12, 2020 | 27 | 2020 |
| Macropinocytosis of Bevacizumab by Glioblastoma cells in the perivascular niche affects their survival G Müller-Greven, CR Carlin, ME Burgett, MS Ahluwalia, A Lauko, ... Clinical Cancer Research 23 (22), 7059-7071, 2017 | 25 | 2017 |
| Sex-biased T cell exhaustion drives differential immune responses in glioblastoma J Lee, M Nicosia, ES Hong, DJ Silver, C Li, D Bayik, DC Watson, A Lauko, ... Cancer Discovery, 2023 | 20 | 2023 |
| SerpinB3 drives cancer stem cell survival in glioblastoma A Lauko, J Volovetz, SM Turaga, D Bayik, DJ Silver, K Mitchell, ... Cell Reports 40 (11), 111348, 2022 | 16 | 2022 |
| Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases A Lauko, R Kotecha, A Barnett, H Li, V Tatineni, A Ali, P Patil, ... Scientific Reports 11 (1), 1-8, 2021 | 16 | 2021 |
| WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma K Mitchell, SA Sprowls, S Arora, S Shakya, DJ Silver, CM Goins, ... Genes & Development 37 (3-4), 86-102, 2023 | 13 | 2023 |
| Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets D Bayik, CF Bartels, K Lovrenert, DC Watson, D Zhang, K Kay, J Lee, ... Cancer research 82 (22), 4274-4287, 2022 | 13 | 2022 |
| Efficacy of immune checkpoint inhibitors in patients with brain metastasis from NSCLC, RCC, and melanoma. A Lauko, B Thapa, X Jia, MS Ahluwalia Journal of Clinical Oncology 36 (5_suppl), 214-214, 2018 | 11 | 2018 |
| Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases A Lauko, B Thapa, M Sharma, B Muhsen, A Barnett, Y Rauf, ... Scientific reports 11 (1), 1-9, 2021 | 10 | 2021 |
| Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles D Bayik, AJ Lauko, GA Roversi, E Serbinowski, LA Acevedo-Moreno, ... Scientific Reports 10 (1), 1-11, 2020 | 10 | 2020 |
| Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer N Hashemi-Sadraei, GM Müller-Greven, FW Abdul-Karim, I Ulasov, ... Journal of neuro-oncology 140 (2), 237-248, 2018 | 9 | 2018 |
| Novel Systemic Treatments for Brain Metastases From Lung Cancer B Thapa, A Lauko, K Desai, VA Venur, MS Ahluwalia Current Treatment Options in Neurology 20 (11), 48, 2018 | 8 | 2018 |
Justin D LathiaProfessor, Cleveland ClinicVerified email at ccf.org
